These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 30320604)
41. Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responses. Chissumba RM; Luciano A; Namalango E; Bauer A; Bhatt N; Wahren B; Nilsson C; Geldmacher C; Scarlatti G; Jani I; Kestens L; Immunobiology; 2018 Dec; 223(12):792-801. PubMed ID: 30121146 [TBL] [Abstract][Full Text] [Related]
42. IFN-γ Attenuates Spontaneous Lymphocyte Proliferation by Fuelling Regulatory T Cells in HIV-1-Infected Patients. Terzieva VI; Popova DN; Elenkov II Viral Immunol; 2017 Apr; 30(3):157-166. PubMed ID: 28051930 [TBL] [Abstract][Full Text] [Related]
43. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Kolte L; Gaardbo JC; Skogstrand K; Ryder LP; Ersbøll AK; Nielsen SD Clin Exp Immunol; 2009 Jan; 155(1):44-52. PubMed ID: 19016807 [TBL] [Abstract][Full Text] [Related]
44. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects. Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018 [TBL] [Abstract][Full Text] [Related]
45. Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects. Cenderello G; De Maria A Expert Rev Anti Infect Ther; 2016; 14(1):29-40. PubMed ID: 26513236 [TBL] [Abstract][Full Text] [Related]
46. Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV. Degaffe G; Zakhour R; Zhang W; Contreras GA; Bell CS; Rodriguez G; Del Bianco G; Pérez N; Benjamins LJ; Murphy JR; Heresi GP; Tran DQ Clin Exp Immunol; 2015 Apr; 180(1):108-17. PubMed ID: 25425428 [TBL] [Abstract][Full Text] [Related]
47. Increased Platelet-CD4 Dai XP; Wu FY; Cui C; Liao XJ; Jiao YM; Zhang C; Song JW; Fan X; Zhang JY; He Q; Wang FS Front Immunol; 2021; 12():799124. PubMed ID: 34987521 [TBL] [Abstract][Full Text] [Related]
48. Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease. Shive CL; Mudd JC; Funderburg NT; Sieg SF; Kyi B; Bazdar DA; Mangioni D; Gori A; Jacobson JM; Brooks AD; Hardacre J; Ammori J; Estes JD; Schacker TW; Rodriguez B; Lederman MM J Infect Dis; 2014 Aug; 210(4):619-29. PubMed ID: 24585897 [TBL] [Abstract][Full Text] [Related]
49. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. Cao W; Jamieson BD; Hultin LE; Hultin PM; Detels R AIDS Res Hum Retroviruses; 2009 Feb; 25(2):183-91. PubMed ID: 19239357 [TBL] [Abstract][Full Text] [Related]
51. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells. Amarnath S; Dong L; Li J; Wu Y; Chen W Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698 [TBL] [Abstract][Full Text] [Related]
52. Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients. Arruvito L; Sabatté J; Pandolfi J; Baz P; Billordo LA; Lasala MB; Salomón H; Geffner J; Fainboim L PLoS One; 2012; 7(12):e52580. PubMed ID: 23285102 [TBL] [Abstract][Full Text] [Related]
53. Regulatory T Cell Counts and Development of Malignancy in Patients with HIV Infection. Politou M; Boti S; Androutsakos T; Kontos A; Pouliakis A; Kapsimali V; Panayiotakopoulos G; Kordossis T; Karakitsos P; Sipsas NV Curr HIV Res; 2020; 18(3):201-209. PubMed ID: 32234003 [TBL] [Abstract][Full Text] [Related]